Literature DB >> 390899

Prostaglandins and serotonin: nonpeptide diarrheogenic hormones.

B M Jaffe.   

Abstract

Prostaglandins and serotonin are vasoactive compounds with profound effects on the gastrointestinal tract. Both cause inhibition of gastric acid secretion (although serotonin stimulates gastric pepsin secretion), stimulation of intestinal motility, and conversion of small intestinal mucosa from absorption to secretion of water and electrolytes. Their effects on pancreatic and biliary function are still not clear. Although prostaglandins appear to elicit their effects primarily by a paracrine mode of action, and serotonin is primarily a neurotransmitter (neurocrine), it is clear that even under normal conditions both can function as humoral agents. For example, we have shown that serotonin plays a physiologic role as a humoral inhibitor of gastric acid secretion. However, the effects of these agents become more pronounced in patients with humorally mediated diarrheogenic syndromes. Serotonin (and related indoles, particularly 5-hydroxytryptophan) has been firmly implicated as a cause of diarrhea in patients with carcinoid syndrome; our recent studies suggest that the diagnosis can be more effectively made by measuring circulating immunoreactive serotonin concentrations than urinary excretion of 5-HIAA; that some circulating serotonin escapes hepatic inactivation and, thus, large intestinal tumors can cause carcinoid syndrome in the absence of hepatic metastases; and that large amounts of serotonin are produced by some noncarcinoid diarrheogenic tumors, including medullary carcinomas of the thyroid and tumors associated with the WDHA syndrome. A large number of tumors of probable neural crest origin, including medullary thyroid carcinoma, carcinoids, and tumors associated with the WDHA syndrome, secrete large amounts of prostaglandins, particularly PGE2. The clinical response of at least some of the patients harboring these tumors to inhibitors of prostaglandin synthesis (particularly indomethacin) suggests that prostaglandins play a role in the etiology of these diarrheogenic syndromes.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 390899     DOI: 10.1007/bf01654761

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  185 in total

1.  Inhibition of gastric acid secretion in the dog by the precursor of serotonin, 5-hydroxytryptophan.

Authors:  B J HAVERBACK; D BOGDANSKI; C A HOGBEN
Journal:  Gastroenterology       Date:  1958-02       Impact factor: 22.682

2.  Watery diarrhea associated with pancreatic islet cell carcinoma.

Authors:  M G Schmitt; K H Soergel; G T Hensley; W Y Chey
Journal:  Gastroenterology       Date:  1975-07       Impact factor: 22.682

3.  Prevention of cholera-induced intestinal secretion in the cat by aspirin.

Authors:  A D Finck; R L Katz
Journal:  Nature       Date:  1972-08-04       Impact factor: 49.962

Review 4.  Serotonin and the alimentary tract.

Authors:  J H Thompson
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1971 Jul-Sep

5.  Effects of vasoactive agents on intestinal blood flow and motility in the dog.

Authors:  Z Shehadeh; W E Price; E D Jacobson
Journal:  Am J Physiol       Date:  1969-02

6.  Effect of oral prostaglandin E1 on intestinal transit in man.

Authors:  J J Misiewicz; S L Waller; N Kiley
Journal:  Lancet       Date:  1969-03-29       Impact factor: 79.321

7.  The effect of 16,16-dimethyl prostaglandin E2 on meal-stimulated gastric acid secretion and serum gastrin in duodenal ulcer patients.

Authors:  A F Ippoliti; J I Isenberg; V Maxwell; J H Walsh
Journal:  Gastroenterology       Date:  1976-04       Impact factor: 22.682

8.  Release of immunoreactive serotonin following acid perfusion of the duodenum.

Authors:  J M Kellum; B M Jaffe
Journal:  Ann Surg       Date:  1976-11       Impact factor: 12.969

9.  Effect of a synthetic analogue of PGE2 on exocrine and endocrine pancreatic function in the rat.

Authors:  G Dodi; M G Santoro; B M Jaffe
Journal:  Surgery       Date:  1978-02       Impact factor: 3.982

10.  Prostaglandin action on pancreatic blood flow and on electrolyte and enzyme secretion by exocrine pancreas in vivo and in vitro.

Authors:  R M Case; T Scratcherd
Journal:  J Physiol       Date:  1972-10       Impact factor: 5.182

View more
  8 in total

1.  Antidiarrheal mechanism and ionic profile of Carpolobia lutea ethanolic stem-bark extract in rats.

Authors:  Lucky Legbosi Nwidu; Orodje Onomor Ukiri; Clenilson Martins Rodrigues; Wagner Vilegas
Journal:  Afr J Tradit Complement Altern Med       Date:  2014-01-28

2.  Prostaglandin E2 is a mediator of 5-hydroxytryptamine induced water and electrolyte secretion in the human jejunum.

Authors:  L K Munck; A Mertz-Nielsen; H Westh; K Bukhave; E Beubler; J Rask-Madsen
Journal:  Gut       Date:  1988-10       Impact factor: 23.059

3.  Carcinoid syndrome from a carcinoid tumor of the pancreas without liver metastases: A case report and literature review.

Authors:  Nikolaos Zavras; Demetrios Schizas; Nikolaos Machairas; Vasileia Damaskou; Nikolaos Economopoulos; Anastasios Machairas
Journal:  Oncol Lett       Date:  2017-02-06       Impact factor: 2.967

4.  The inhibitory effects of 5-hydroxytryptamine on gastric acid secretion by the rat isolated stomach.

Authors:  S P Canfield; J E Spencer
Journal:  Br J Pharmacol       Date:  1983-01       Impact factor: 8.739

Review 5.  Neuropathophysiology of functional gastrointestinal disorders.

Authors:  Jackie D Wood
Journal:  World J Gastroenterol       Date:  2007-03-07       Impact factor: 5.742

6.  Carcinoid tumors of the appendix.

Authors:  A Roggo; W C Wood; L W Ottinger
Journal:  Ann Surg       Date:  1993-04       Impact factor: 12.969

7.  The effect of carcinoid levels of serotonin and substance P on hemodynamics.

Authors:  M J Zinner; C J Yeo; B M Jaffe
Journal:  Ann Surg       Date:  1984-02       Impact factor: 12.969

8.  Protective effect of Arque-Ajeeb on acute experimental diarrhoea in rats.

Authors:  Mohd Aleem Khan; Naeem Ahmad Khan; Iqbal Ahmad Qasmi; Ghufran Ahmad; Shadab Zafar
Journal:  BMC Complement Altern Med       Date:  2004-07-06       Impact factor: 3.659

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.